Merrimack Pharmaceuticals
MACK
#8766
Rank
ยฃ0.17 B
Marketcap
ยฃ11.56
Share price
0.00%
Change (1 day)
3.15%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): ยฃ10.97

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ10.59. In 2016 the company made an earnings per share (EPS) of -ยฃ9.34 an increase over its 2015 EPS that were of -ยฃ10.08.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)ยฃ10.97
2016-ยฃ9.34-7.35%
2015-ยฃ10.0865%
2014-ยฃ6.11-39.39%
2013-ยฃ10.08-54.01%
2012-ยฃ21.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
ยฃ1.51-85.71%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
-ยฃ0.06111-100.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-ยฃ1.44-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-ยฃ0.64-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ22.37-311.33%๐Ÿ‡บ๐Ÿ‡ธ USA